A feature that could differentiate the insulin therapy in WS compared to T1D autoimmune patients, in which there is an acute destruction of β cells, could also be the lack or, on the contrary, the extension of the honey moon period. This evidence concerns the gene INS and type 1 diabetes mellitus.